N.H. U.S. Attorney: Arizona Company and CEO Plead Guilty to the Distribution of Drugs Not Approved by the FDA and Will Pay $2.4 Million
October 31, 2023
October 31, 2023
CONCORD, New Hampshire, Oct. 31 -- The U.S. Attorney for the District of New Hampshire, Jane E. Young, issued the following news release on Oct. 30, 2023:
An Arizona company and CEO pleaded guilty today in federal court in Concord for distributing drugs into the interstate commerce that were not approved by the Food and Drug Administration (FDA), U.S. Attorney Jane E. Young announces.
Centera Bioscience, d/b/a Nootropics Depot, and its CEO, Paul Eftang, 38, pleaded guil . . .
An Arizona company and CEO pleaded guilty today in federal court in Concord for distributing drugs into the interstate commerce that were not approved by the Food and Drug Administration (FDA), U.S. Attorney Jane E. Young announces.
Centera Bioscience, d/b/a Nootropics Depot, and its CEO, Paul Eftang, 38, pleaded guil . . .